Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disease-Free Survival”

481 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 481 results

Post-approval studies (Phase 4)Study completedNCT00108862
What this trial is testing

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

Who this might be right for
HIV InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 809
Testing effectiveness (Phase 2)Ended earlyNCT00474188
What this trial is testing

Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene Corporation 26
Testing effectiveness (Phase 2)Looking for participantsNCT06137378
What this trial is testing

European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]

Who this might be right for
Squamous Cell Carcinoma of Head and NeckHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma Stage III+9 more
University of Leipzig 140
Testing effectiveness (Phase 2)Study completedNCT03801915
What this trial is testing

Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

Who this might be right for
Colon CancerPancreatic CancerCholangiocarcinoma+2 more
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Ended earlyNCT05386550
What this trial is testing

Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)

Who this might be right for
Head and Neck Cancer
EMD Serono Research & Development Institute, Inc. 166
Not applicableStudy completedNCT00834158
What this trial is testing

Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 20
Not applicableUnknownNCT05845632
What this trial is testing

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

Who this might be right for
Carcinoma, Squamous CellSkin CancerCarcinoma, Squamous Cell, Skin+3 more
Maastricht University Medical Center 965
Not applicableStudy completedNCT02030002
What this trial is testing

Evaluation of a "Flash-free" Adhesive Resin for Orthodontic Bracket Bonding

Who this might be right for
Malocclusion
University of Minnesota 49
Not applicableEnded earlyNCT00288275
What this trial is testing

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Precision Therapeutics 256
Testing effectiveness (Phase 2)UnknownNCT02595021
What this trial is testing

Total/Subtotal Colectomy in Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+1 more
Shanghai Gynecologic Oncology Group 80
Large-scale testing (Phase 3)Active Not RecruitingNCT01805271
What this trial is testing

Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy

Who this might be right for
Primary Non-metastatic Breast CancerWho Remain Disease-free
UNICANCER 1,278
Not applicableActive Not RecruitingNCT03958136
What this trial is testing

Clinico-biological Data Collection Study of Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Institut Cancerologie de l'Ouest 289
Testing effectiveness (Phase 2)UnknownNCT02739204
What this trial is testing

Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma
China Medical University Hospital 270
Testing effectiveness (Phase 2)Study completedNCT00256711
What this trial is testing

Phase II Iressa Versus Vinorelbine (INVITE)

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca 192
Not applicableLooking for participantsNCT06088134
What this trial is testing

Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Clear Cell Renal Cell CarcinomaPrognostic Cancer ModelRecurrent Renal Cell Cancer
Mingzhao Xiao 800
Not applicableLooking for participantsNCT04805255
What this trial is testing

A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT

Who this might be right for
Brain Metastases, Adult
Chang Gung Memorial Hospital 135
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07528768
What this trial is testing

Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerMetastatic Triple-negative Breast Cancer
AntiCancer Research Jamaica 750
Testing effectiveness (Phase 2)Study completedNCT00748358
What this trial is testing

An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasms, Hormone-DependentTumor Markers, Biological+2 more
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Study completedNCT01110668
What this trial is testing

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor
Novartis Pharmaceuticals 2
Large-scale testing (Phase 3)Study completedNCT00929240
What this trial is testing

Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 287
Load More Results